One year of treatment with dapirolizumab pegol can reduce fatigue and ease disease activity in people with systemic lupus erythematosus (SLE), according to new results from a Phase 3 clinical trial. Findings from the trial, called PHOENYCS GO (NCT04294667), were shared by UCB and Biogen, the two companies developing…
Read more
I think I’ve fallen in a “Doctor Who” rabbit hole. If you’ve ever watched the show, you know the TARDIS, whose letters stand for time and relative dimension in space. On the outside, it looks like a simple blue British police box, plain and unassuming. But step inside,…
Lupus is an autoimmune inflammatory disease that can affect multiple systems in the body.
While the cause of lupus is often unknown, it is possibly due to a combination of genetics and the environment.
Lupus affects people in different ways, and symptoms vary among patients. Symptoms come and go during periods called flares.
